Dr. Doris Mbithi, one of just three obstetrician-gynecologist surgeons serving the entirety of Kenya’s Makueni County, was on her way to a morning meeting at the Mother and Child Hospital, the maternity section of the county’s largest referral facility, when she was alerted about an incoming patient. The woman, several weeks post-delivery, was bleeding profusely.
AMPLI – PPHI Accelerating Measurable Progress and Leveraging Investments for Postpartum Hemorrhage Impact News To Know: PATH and Jhpiego just launched a call for Expression of Interest (EOI) to identify potential industry partners that can contribute to improving access to life-saving medicines in low- and middle-income countries to prevent and treat postpartum hemorrhage. Manufacturers of misoprostol tablets and tranexamic acid injectables are encouraged to apply! Did you know? Postpartum hemorrhage
August 16, 2022 Baltimore, MD—Jhpiego, a global leader in maternal health care, has been chosen to lead a new $18.5 million project funded by Unitaid that will inform how countries can introduce and accelerate use of key drugs to prevent and treat life-threatening bleeding after birth. The Accelerating Measurable Progress and Leveraging Investments for Postpartum
